Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Novoheart Holdings Inc. V.NVH

"Novoheart Holdings Inc is a Canadian based company. It is engaged in the engineering bio-artificial human heart tissues and chambers for drug discovery, cardiotoxicity screening, disease modeling and future therapeutic applications. Novoheart's scientific team has pioneered a range of bioengineering technologies collectively known as the MyHeart platform, including first human mini-heart... see more

Bullboard (TSXV:NVH)

View:
Post by imtheguyon Jul 19, 2020 11:15pm

Slowwwww

Looks nothing to report here? All other bio stocks are booming but this one is dead. Maybe they are having problems cause of Covid?
Post by Panarboron Nov 26, 2019 1:11pm

Tenbagger Novoheart

Novoheart To Co-develop Human Heart-in-a-Jar Model Of Heart Failure With AZN LONDON (dpa-AFX) - Novoheart said that it has collaborated with AstraZeneca to develop the world's first ...more  
Post by RobZatriani38on Sep 05, 2019 11:52pm

The real numbers behind NVH revealed

Check this  out  https://cutt.ly/0wm93or
Comment by imtheguyon Jun 10, 2019 5:57am

RE:Huge Day June 26th

Nothing special. Just to approve the deal. Something smells of fish to me. They take over a new company with seems only a lot of money but no business. Anybody got an idea? Why? Fish t'm telling ...more  
Post by Aberta1on Jun 05, 2019 2:09pm

Huge Day June 26th

Special meeting NVH
Post by imtheguyon Apr 16, 2019 10:29am

Israeli Researchers Print 3D Heart Using Patient’s Own Cells

Saw this in many articles today. I am wonder if this is bad for NVH? Any comments? This seems to me very faster and more like a real heart! Also wonder why this stockhouse is using the older symbol ...more  
Post by Aberta1on Dec 20, 2018 2:19pm

Stem Cells at the Heart of Medical Innovation

https://www.asiaoutlookmag.com/magazine/asia-outlook-issue-36/8
Post by imtheguyon Dec 14, 2018 3:35am

Stuck

Well. Cannaccord was involved to the first financing at 0.50 cents so this makes sense. But they are also very rutheless. I imagine a financing at 0.25 and they will demand a warrant. This NVH price ...more  
Comment by Aberta1on Dec 13, 2018 11:24am

RE:RE:RE:Xellera

Answers to funding and where funding could come from maybe soon. https://www.globalive.com/media/planting-new-roots/
Comment by imtheguyon Dec 11, 2018 1:55am

RE:RE:Xellera

Seems to be the markets does not like it very much. No sounds here. The company must be having no money now either. When will they raise money!?!?! Morrrrrreeee dilution.
Comment by LiquidRealityon Nov 13, 2018 3:38am

RE:Xellera

Why fishy? This is great. It diversifies NVH business model, and shoots for an actual GMP facility. I guess this is Dr. Li's way of adding more value to this company, in something he was already ...more  
Post by imtheguyon Nov 09, 2018 1:34am

Xellera

That deal look a bit fishy to me. Any guy have some other thoughts? What is happening with this company? They do not looks to care much about the market price, but about their financials it looks like ...more  
Post by Aberta1on Sep 20, 2018 11:44am

September Volume

The volume in September to date is close to all the volume in June/July/August. Itwo nsiders purchased approx 13% of that volume in those 3 months of June/July/August.
Post by Aberta1on Aug 17, 2018 9:52am

Novoheart collaborating with Joseph Nathan from Pfizer

@Novoheart has been collaborating with Joseph Nabhan from @pfizer to build a disease model of Friedreich's Ataxia, a progressive neurodegenerative disease resulting in fatal heart complications ...more  
Post by Aberta1on Aug 17, 2018 9:31am

HEART OF THE PROBLEM – KEVIN COSTA, CSO

https://www.futuretechpodcast.com/podcasts/heart-problem-kevin-costa-cso-scientific-co-founder-novoheart-stem-cells-tissue-engineering-challenge-defeat-human-heart-conditions-diseases/ Novoheart’s ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities